Elequin Capital LP Tekla Life Sciences Investors Transaction History

Elequin Capital LP

$1.04 Billion
Q1 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 14, 2024	SELL	$11.35 - $13.6 $187,978 - $225,243	-16,562 Reduced 73.04%	6,113 $82,000
Q3 2023 Nov 14, 2023	BUY	$12.38 - $13.69 $280,716 - $310,420	22,675 New	22,675 $282,000
Q1 2023 May 11, 2023	SELL	$13.37 - $14.94 $112,976 - $126,243	-8,450 Reduced 38.75%	13,356 $186,000
Q4 2022 Feb 09, 2023	BUY	$13.55 - $15.23 $295,471 - $332,105	21,806 New	21,806 $309,000

Others Institutions Holding HQL

# of Institutions

80

Shares Held

8.52M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

2.46M
Shares

$32.8 Million
0.58% of portfolio
Morgan Stanley New York, NY

484K
Shares

$6.45 Million
0.0% of portfolio
1607 Capital Partners, LLC Richmond, VA

481K
Shares

$6.41 Million
0.54% of portfolio
Allspring Global Investments Holdings, LLC

431K
Shares

$5.75 Million
0.01% of portfolio
Aqr Arbitrage LLC Greenwich, CT

387K
Shares

$5.16 Million
0.32% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Elequin Capital LP with notifications on news.